ARG1 and neoplasm: Their accumulation within the tumor microenvironment (TME) or peripheral blood as circulating MDSCs has influenced CRC progression through stimulation of tumor neovasculogenesis and facilitating local immunosuppression by inhibiting T cell proliferation through secretion of arginase 1 (ARG1) and inducible nitric oxide synthase (iNOS) [5].